Similar to This
Previous
Profile picture of tagesschau.de
tagesschau.de
Credibility A
 Oct 15
UniCredit gets the green light from the ECB for the takeover of Commerzbank: The Italian banking giant UniCredit has been pursuing Commerzbank for two years ...
tagesschau.de/wirtschaft/ezb-uebernahme-commerzbank-100.html
UniCredit gets the green light from the ECB for the takeover of ...
7 similar articles
37
60
Profile picture of Lebensmittel Zeitung
Lebensmittel Zeitung
C
 Oct 14
Financing: Why the Commerzbank takeover is worrying medium-sized businesses: Commerzbank's focus will narrow considerably in the future. Following the ...
lebensmittelzeitung.net/handel/nachrichten/finanzierung-warum-die-commerzbank-uebernahme-den-mittelstand-beunruhigt-193617
Financing: Why the Commerzbank takeover is worrying medium-sized ...
0 similar articles
0
0
Profile picture of stuttgarter-nachrichten.de
stuttgarter-nachrichten.de Oct 06
OpinionMillion-dollar bonuses: Boris Palmer rants: Payments to CureVac manager "outrageous"
stuttgarter-nachrichten.de/wirtschaft/millionen-boni-boris-palmer-empoerend-hohe-zahlungen-an-curevac-manager-79539819.html
Million-dollar bonuses: Boris Palmer rants: Payments to CureVac manager ...
1 similar article
0
4
Profile picture of Süddeutsche Zeitung
Süddeutsche Zeitung
B+
 Sep 19
CureVac in Tübingen: Takeover by BioNTech and sites in danger: BioNTech acquired CureVac for $1.25 billion at the end of last year and will now close all CureVac ...
sueddeutsche.de/wirtschaft/ugur-sahin-oezlem-tuereci-ingmar-hoerr-struengmann-mrna-impfstoffe-mrna-krebs-moderna-li.3522088
CureVac in Tübingen: Takeover by BioNTech and sites in danger
0 similar articles
0
2
2
5
0
0
2
3
4
5
0
0
Profile picture of Gießener Allgemeine Zeitung
Gießener Allgemeine Zeitung
C
 Mar 11
Humble Games: Former senior employees take over game catalog - | Renamed Balor Games
giessener-allgemeine.de/ratgeber/games/humble-games-ehemalige-fuehrende-mitarbeiter-uebernehmen-spielekatalog-umbenennung-zu-balor-games-zr-94212413.html
Humble Games: Former senior employees take over game catalog - | Renamed ...
1 similar article
0
0
Profile picture of Mittelhessen
Mittelhessen
C
 Jan 07
Bayer Group surprisingly sues Mainz-based BioNTech - | here's the background: No sooner has the patent dispute with CureVac been settled through the takeover ...
mittelhessen.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/bayer-verklagt-ueberraschend-biontech-was-ist-da-los-5297243
Bayer Group surprisingly sues Mainz-based BioNTech - | here's the ...
3 similar articles
0
2
Profile picture of Handelsblatt
Handelsblatt
B+
 Dec 18 25
Biotech: BioNTech finalizes CureVac acquisition: The merger of the two vaccine developers is complete. BioNTech is acquiring its competitor CureVac - | and thus ...
handelsblatt.com/unternehmen/industrie/biotech-biontech-macht-uebernahme-von-curevac-perfekt/100185010.html
Biotech: BioNTech finalizes CureVac acquisition
1 similar article
0
0
Profile picture of swp.de
swp.de
C+
 Dec 03 25
80 percent of shares acquired: CureVac billion-euro deal with BioNTech close to completion
swp.de/lokales/tuebingen/80-prozent-der-aktien-uebernommen-curevac-milliarden-deal-mit-biontech-kurz-vor-abschluss-78493611.html
80 percent of shares acquired: CureVac billion-euro deal with BioNTech ...
4 similar articles
0
0
Profile picture of Mittelhessen
Mittelhessen
C
 Oct 30 25
BioNTech launches major video campaign for at-risk groups regarding COVID-19 vaccination
mittelhessen.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/biontech-faehrt-grosse-video-kampagne-zu-corona-impfung-5111619
BioNTech launches major video campaign for at-risk groups regarding ...
4 similar articles
0
55
Profile picture of stuttgarter-nachrichten.de
stuttgarter-nachrichten.de Oct 22 25
Share swap - | Biontech launches offer to Curevac shareholders: The deadline for the share swap is December 3rd. The former competitors plan to conduct joint ...
stuttgarter-nachrichten.de/inhalt.aktientausch-biontech-startet-angebot-an-curevac-aktionaere.9753c233-bf64-4877-8fed-36fe7b77f02d.html
Share swap - | Biontech launches offer to Curevac shareholders
3 similar articles
0
0
Profile picture of Gießener Allgemeine Zeitung
Gießener Allgemeine Zeitung
C
 Oct 14 25
Antitrust authority approves BioNTech's acquisition of CureVac: Why do competition watchdogs see no threat to innovation in the merger between BioNTech and ...
giessener-allgemeine.de/wirtschaft/kartellamt-erlaubt-kauf-von-curevac-durch-biontech-zr-93985421.html
Antitrust authority approves BioNTech's acquisition of CureVac
8 similar articles
0
0
Profile picture of deraktionaer.de
deraktionaer.de
C
 Oct 14 25
Commerzbank: job cuts as a defensive measure in the takeover battle: Commerzbank plans to cut 3,900 jobs worldwide by 2028 to ward off a takeover by UniCredit.
deraktionaer.de/artikel/fintech-versicherung-banken/commerzbank-stellenabbau-als-abwehrmassnahme-im-uebernahmekampf-20388279.html
Commerzbank: job cuts as a defensive measure in the takeover battle
0 similar articles
0
1
Profile picture of Frankfurter Rundschau
Frankfurter Rundschau
B
 Sep 05 25
Unicredit CEO on Commerzbank purchase: "We have a plan": Unicredit plans to increase its stake in Commerzbank to around 30 percent soon. CEO Orcel is already ...
fr.de/wirtschaft/unicredit-chef-zu-commerzbank-kauf-wir-haben-einen-plan-zr-93916716.html
Unicredit CEO on Commerzbank purchase:
6 similar articles
0
1
Profile picture of Handelsblatt
Handelsblatt
B+
 Aug 04 25
Pharma industry: Biontech halves loss - cancer strategy picks up speed: Biontech more than doubled its turnover in the second quarter. The company plans to spend ...
handelsblatt.com/unternehmen/industrie/pharmaindustrie-biontech-halbiert-verlust-krebsstrategie-nimmt-fahrt-auf/100146054.html
Pharma industry: Biontech halves loss - cancer strategy picks up speed
Key FactsBiontech Boosts Growth with Cancer Strategy and Deals
Aug 4, 2025 · Reading time: ~45 sec.
Summary created with AI assistance · Source: handelsblatt.com
  • Biontech doubled its revenue to €260.8 million in Q2 and reduced its net loss to €386.6 million.

  • The company is refocusing on oncology, strengthened by a partnership with Bristol Myers Squibb and the planned acquisition of Curevac.

  • Over 20 studies involving BNT327 across various tumors are underway, with a pivotal breast cancer phase-3 study starting this year.

  • Revenue is forecasted to decline in 2025 while R&D spending is expected to increase to as much as €2.8 billion.
    • We continue to invest significantly in the implementation of our strategy, and our operational and financial measures are showing initial tangible results.
    — CFO Ramón Zapata discusses Biontech's progress in cancer research.
7 similar articles
17
127
Profile picture of Mittelhessen
Mittelhessen
C
 Jun 18 25
Biontech swallows Curevac: A billionaire paves the way: No question: Biontech has pulled off a coup with the takeover of Curevac. But what prompted Curevac to ...
mittelhessen.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/biontech-schluckt-curevac-ein-milliardaer-macht-den-weg-frei-4722890
Biontech swallows Curevac: A billionaire paves the way
Key FactsBiontech Acquires Curevac with Billionaire Support
Jun 18, 2025 · Reading time: ~45 sec.
Summary created with AI assistance · Source: mittelhessen.de
  • Biontech finalized the acquisition of Curevac in June 2025, expanding its capabilities in RNA technology.

  • SAP billionaire Dietmar Hopp holds over one-third of Curevac shares through investment firms, facilitating the transaction.

  • The takeover is viewed by Biontech as a key element in enhancing its oncology strategy and future cancer therapies.

  • Curevac founder Ingmar Hoerr expressed regret that the Curevac brand will disappear following the acquisition.
    • This transaction is another building block in Biontech's oncology strategy and an investment in the future of cancer medicine.
    — Ugur Sahin, CEO and co-founder of Biontech, discussing the significance of the acquisition of Curevac.
3 similar articles
0
3
Next